WO2025233676 - COMPOSITIONS AND METHODS RELATED TO A COMBINATION THERAPY OF STING AGONISTS AND IMMUNE CHECKPOINT INHIBITORS
National phase entry is expected:
Publication Number
WO/2025/233676
Publication Date
13.11.2025
International Application No.
PCT/IB2025/000222
International Filing Date
08.05.2025
Title **
[English]
COMPOSITIONS AND METHODS RELATED TO A COMBINATION THERAPY OF STING AGONISTS AND IMMUNE CHECKPOINT INHIBITORS
[French]
COMPOSITIONS ET MÉTHODES ASSOCIÉES À UNE POLYTHÉRAPIE FAISANT APPEL À DES AGONISTES DE STING ET DES INHIBITEURS DE POINTS DE CONTRÔLE IMMUNITAIRES
Applicants **
LIGACHEM BIOSCIENCES INC.
CHANG, Sook Kyung
OH, Jihye
JANG, Yeseul
SONG, Ho Young
KIM, Sung Min
CHUNG, Chul-Woong
Inventors
CHANG, Sook Kyung
OH, Jihye
JANG, Yeseul
SONG, Ho Young
KIM, Sung Min
CHUNG, Chul-Woong
Priority Data
63/644,231
08.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6640 | |
| EPO | Filing, Examination, Granting | 67317 | |
| Japan | Filing, Examination, Granting | 3942 | |
| South Korea | Filing, Examination, Granting | 3975 | |
| USA | Filing, Examination, Granting | 17840 |
Total:
99,714
Contact Us
Abstract[English]
The disclosure provides combination therapy methods of treating diseases (such as cancer) comprising a compound represented by formula (I), or a pharmaceutically acceptable salt thereof and an immune checkpoint inhibitor.[French]
L'invention concerne des méthodes de polythérapie pour le traitement de maladies (telles que le cancer) comprenant un composé représenté par la formule (I), ou un sel pharmaceutiquement acceptable de celui-ci et un inhibiteur de point de contrôle immunitaire.